Pular para o conteúdo
Tumor das meninges
ORPHA:252025DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
lung

Neoplasia benigna ou maligna que afeta as meninges. A maioria das neoplasias surge de células meningoteliais e são chamadas de meningiomas. As neoplasias de células não meningoteliais incluem tumores mesenquimais, não meningoteliais, hemangiopericitomas e lesões melanocíticas.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

O tumor das meninges é um tipo de tumor que afeta as camadas protetoras que envolvem o cérebro e a medula espinhal, sendo os meningiomas as formas mais conhecidas. Ao crescer, ele pode provocar sintomas como dores de cabeça por pressão no crânio, náuseas, vômitos, perda de força nas pernas e alterações na fala ou na memória. Esta condição não possui um protocolo clínico específico (PCDT) nem remédios próprios dispensados pela lista de doenças raras do SUS. Por isso, o cuidado e o acompanhamento devem ser conduzidos diretamente com a equipe médica nos hospitais de referência.

📋
Informacoes curadas por IA — podem conter imprecisoes

Neoplasia benigna ou maligna que afeta as meninges. A maioria das neoplasias surge de células meningoteliais e são chamadas de meningiomas. As neoplasias de células não meningoteliais incluem tumores mesenquimais, não meningoteliais, hemangiopericitomas e lesões melanocíticas.

Pesquisas ativas
90 ensaios
226 total registrados no ClinicalTrials.gov
Publicações científicas
4 artigos
Último publicado: 2018 Apr-Jun
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
10 sintomas
📏
Crescimento
9 sintomas
👁️
Olhos
4 sintomas
💪
Músculos
3 sintomas
🫁
Pulmão
2 sintomas
🫘
Rins
2 sintomas

+ 40 sintomas em outras categorias

Características mais comuns

—
Concentração sérica de testosterona diminuída
—
Neoplasia da língua
—
Morfologia anormal do mediastino
—
Comprometimento progressivo da função pulmonar
—
Anormalidade da fala ou vocalização
—
Hemorragia cerebral
76sintomas
Sem dados (76)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 76 características clínicas mais associadas, ordenadas por frequência.

Concentração sérica de testosterona diminuídaDecreased serum testosterone concentration
Neoplasia da línguaNeoplasm of the tongue
Morfologia anormal do mediastinoAbnormality of the mediastinum
Comprometimento progressivo da função pulmonarProgressive pulmonary function impairment
Anormalidade da fala ou vocalizaçãoAbnormality of speech or vocalization

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa8desde 2018
Total histórico4PubMed
Últimos 10 anos1publicações
Pico20181 papers
Linha do tempo
20202018Hoje · 2026🧪 1983Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

13 genes identificados com associação a esta condição.

MN1Transcriptional activator MN1Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

CEBALID syndrome

An autosomal dominant developmental disorder characterized by global developmental delay, intellectual disability with severe expressive language delay, craniofacial dysmorphism, and structural brain abnormalities. Most patients have an atypical form of rhombencephalosynapsis, a distinctive brain malformation characterized by partial or complete loss of the cerebellar vermis with fusion of the cerebellar hemispheres. Other frequent features include perisylvian polymicrogyria, abnormal posterior clinoid processes, cerebellar hypoplasia or dysplasia, and persistent trigeminal artery.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
46.4 TPM
Músculo esquelético
35.8 TPM
Aorta
35.1 TPM
Artéria coronária
27.7 TPM
Esôfago - Junção
22.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (3)
familial meningiomaCEBALID syndromefamilial multiple meningioma
HGNC:7180UniProt:Q10571
PTENPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTENCandidate gene tested inRestrito
VIAS BIOLÓGICAS (10)
Synthesis of PIPs at the plasma membraneDownstream TCR signalingNegative regulation of the PI3K/AKT networkTP53 Regulates Metabolic GenesSynthesis of IP3 and IP4 in the cytosol
MECANISMO DE DOENÇA

Cowden syndrome 1

An autosomal dominant hamartomatous polyposis syndrome with age-related penetrance. Cowden syndrome is characterized by hamartomatous lesions affecting derivatives of ectodermal, mesodermal and endodermal layers, macrocephaly, facial trichilemmomas (benign tumors of the hair follicle infundibulum), acral keratoses, papillomatous papules, and elevated risk for development of several types of malignancy, particularly breast carcinoma in women and thyroid carcinoma in both men and women. Colon cancer and renal cell carcinoma have also been reported. Hamartomas can be found in virtually every organ, but most commonly in the skin, gastrointestinal tract, breast and thyroid.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
62.5 TPM
Cervix Ectocervix
62.4 TPM
Cervix Endocervix
59.7 TPM
Fallopian Tube
51.0 TPM
Cérebro - Hemisfério cerebelar
49.1 TPM
OUTRAS DOENÇAS (19)
Cowden syndrome 1prostate cancer, hereditaryPTEN hamartoma tumor syndromemacrocephaly-autism syndrome
HGNC:9588UniProt:P60484
AKT1RAC-alpha serine/threonine-protein kinaseCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (7)
CD28 dependent PI3K/Akt signalingVEGFR2 mediated vascular permeabilityPIP3 activates AKT signalingNegative regulation of the PI3K/AKT networkG beta:gamma signalling through PI3Kgamma
MECANISMO DE DOENÇA

Breast cancer

A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.

OUTRAS DOENÇAS (7)
ovarian cancerProteus syndromehereditary breast carcinomacolorectal cancer
HGNC:391UniProt:P31749
TERTTelomerase reverse transcriptaseCandidate gene tested inRestrito
VIAS BIOLÓGICAS (3)
Telomere Extension By TelomeraseFormation of the beta-catenin:TCF transactivating complexRegulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.7 TPM
Intestino delgado
0.7 TPM
Brain Caudate basal ganglia
0.6 TPM
Cólon transverso
0.5 TPM
Brain Nucleus accumbens basal ganglia
0.5 TPM
OUTRAS DOENÇAS (13)
dyskeratosis congenita, autosomal dominant 2pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1adrenal cortex carcinomaclear cell sarcoma of kidney
HGNC:11730UniProt:O14746
PIK3CAPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
Signaling by LTK in cancerNephrin family interactionsIRS-mediated signallingTie2 SignalingDAP12 signaling
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
23.2 TPM
Linfócitos
22.4 TPM
Nervo tibial
21.4 TPM
Tecido adiposo
20.5 TPM
Fibroblastos
20.5 TPM
OUTRAS DOENÇAS (28)
seborrheic keratosismegalodactylyovarian cancerhepatocellular carcinoma
HGNC:8975UniProt:P42336
BAP1Ubiquitin carboxyl-terminal hydrolase BAP1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaksUCH proteinases
OUTRAS DOENÇAS (8)
Kury-Isidor syndromeBAP1-related tumor predisposition syndromecomplex neurodevelopmental disordermeningioma
HGNC:950UniProt:Q92560
SMARCB1SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (8)
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not knownRMTs methylate histone argininesFormation of neuronal progenitor and neuronal BAF (npBAF and nBAF)Formation of the embryonic stem cell BAF (esBAF) complexFormation of the polybromo-BAF (pBAF) complex
MECANISMO DE DOENÇA

Rhabdoid tumor predisposition syndrome 1

A familial cancer syndrome predisposing to renal or extrarenal malignant rhabdoid tumors and to a variety of tumors of the central nervous system, including choroid plexus carcinoma, medulloblastoma, and central primitive neuroectodermal tumors. Rhabdoid tumors are the most aggressive and lethal malignancies occurring in early childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
136.4 TPM
Testículo
110.5 TPM
Cérebro - Hemisfério cerebelar
98.7 TPM
Cerebelo
93.5 TPM
Ovário
93.2 TPM
OUTRAS DOENÇAS (9)
rhabdoid tumor predisposition syndrome 1intellectual disability, autosomal dominant 15familial multiple meningiomaschwannomatosis
HGNC:11103UniProt:Q12824
SMOProtein smoothenedCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Hedgehog 'off' state
EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
62.8 TPM
Ovário
60.7 TPM
Cervix Ectocervix
56.8 TPM
Útero
50.1 TPM
Pituitária
38.7 TPM
OUTRAS DOENÇAS (5)
congenital hypothalamic hamartoma syndromebasal cell carcinoma, susceptibility to, 1Curry-Jones syndromemeningioma
HGNC:11119UniProt:Q99835
TRAF7E3 ubiquitin-protein ligase TRAF7Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Antigen processing: Ubiquitination & Proteasome degradation
MECANISMO DE DOENÇA

Cardiac, facial, and digital anomalies with developmental delay

An autosomal dominant disorder characterized by delayed motor and speech development, developmental regression, congenital heart defects, limb and digital anomalies, and dysmorphic features. Cardiac features include pulmonary stenosis, patent ductus arteriosus, aortic coarctation, valvular defects, hypoplastic left heart, double outlet right ventricle, and conduction abnormalities. Dysmorphic facial features include multiple hair whorls or hairline abnormalities, ptosis, epicanthal folds, and low-set or dysplastic ears.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
87.5 TPM
Esôfago - Mucosa
70.4 TPM
Skin Sun Exposed Lower leg
68.9 TPM
Linfócitos
65.8 TPM
Fallopian Tube
64.5 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (3)
cardiac, facial, and digital anomalies with developmental delaymeningiomaTRAF7-associated heart defect-digital anomalies-facial dysmorphism-motor and speech delay syndrome
HGNC:20456UniProt:Q6Q0C0
SMARCE1SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (8)
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not knownRMTs methylate histone argininesFormation of neuronal progenitor and neuronal BAF (npBAF and nBAF)Formation of the embryonic stem cell BAF (esBAF) complexFormation of the polybromo-BAF (pBAF) complex
MECANISMO DE DOENÇA

Meningioma

A common neoplasm of the central nervous system derived from arachnoidal cells. The majority of meningiomas are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Most cases are sporadic. Familial occurrence of meningioma is rare.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
58.4 TPM
Cervix Endocervix
51.0 TPM
Fibroblastos
47.8 TPM
Artéria tibial
45.6 TPM
Cervix Ectocervix
45.5 TPM
OUTRAS DOENÇAS (5)
Coffin-Siris syndrome 5familial multiple meningiomameningiomaCoffin-Siris syndrome
HGNC:11109UniProt:Q969G3
SUFUSuppressor of fused homologCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (4)
GLI3 is processed to GLI3R by the proteasomeHedgehog 'off' stateDegradation of GLI1 by the proteasomeDegradation of GLI2 by the proteasome
MECANISMO DE DOENÇA

Medulloblastoma

Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
19.1 TPM
Testículo
17.1 TPM
Skin Not Sun Exposed Suprapubic
16.1 TPM
Nervo tibial
15.3 TPM
Útero
14.5 TPM
OUTRAS DOENÇAS (11)
Joubert syndrome 32basal cell nevus syndrome 2familial multiple meningiomamedulloblastoma with extensive nodularity
HGNC:16466UniProt:Q9UMX1
PDGFBPlatelet-derived growth factor subunit BDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (8)
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingPIP3 activates AKT signalingConstitutive Signaling by Aberrant PI3K in CancerDownstream signal transductionRAF/MAP kinase cascade
MECANISMO DE DOENÇA

Basal ganglia calcification, idiopathic, 5

A form of basal ganglia calcification, an autosomal dominant condition characterized by symmetric calcification in the basal ganglia and other brain regions. Affected individuals can either be asymptomatic or show a wide spectrum of neuropsychiatric symptoms, including parkinsonism, dystonia, tremor, ataxia, dementia, psychosis, seizures, and chronic headache. Serum levels of calcium, phosphate, alkaline phosphatase and parathyroid hormone are normal. The neuropathological hallmark of the disease is vascular and pericapillary calcification, mainly of calcium phosphate, in the affected brain areas.

EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
49.1 TPM
Pulmão
45.8 TPM
Adipose Visceral Omentum
43.1 TPM
Mama
34.1 TPM
Tireoide
30.5 TPM
OUTRAS DOENÇAS (6)
familial meningiomabasal ganglia calcification, idiopathic, 5familial multiple meningiomameningioma
HGNC:8800UniProt:P01127
NF2MerlinDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Regulation of actin dynamics for phagocytic cup formationRHO GTPases activate PAKs
MECANISMO DE DOENÇA

Schwannomatosis, vestibular

An autosomal dominant neoplasia syndrome characterized by the development of multiple benign nerve sheath tumors called schwannomas, particularly affecting the vestibular nerve. Affected individuals usually present with bilateral vestibular schwannomas but can have schwannomas on other cranial, spinal, and peripheral/cutaneous nerves. Meningiomas are common, whereas 20 to 35% of affected individuals develop intramedullary spinal cord tumors called ependymomas. The condition is also characterized by several ophthalmic features such as lenticular opacities, retinal hamartoma, epiretinal membranes.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
30.4 TPM
Cérebro - Hemisfério cerebelar
27.6 TPM
Córtex cerebral
25.9 TPM
Fibroblastos
25.9 TPM
Brain Frontal Cortex BA9
24.3 TPM
OUTRAS DOENÇAS (5)
NF2-related schwannomatosisfamilial meningiomamosaic NF2-related schwannomatosismeningioma
HGNC:7773UniProt:P35240

Variantes genéticas (ClinVar)

2.225 variantes patogênicas registradas no ClinVar.

🧬 MN1: NM_002430.3(MN1):c.500C>T (p.Pro167Leu) ()
🧬 MN1: NM_002430.3(MN1):c.3724G>T (p.Asp1242Tyr) ()
🧬 MN1: NM_002430.3(MN1):c.1980C>G (p.Asp660Glu) ()
🧬 MN1: NM_002430.3(MN1):c.1827del (p.Ser609fs) ()
🧬 MN1: NM_002430.3(MN1):c.3449T>C (p.Ile1150Thr) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

93 vias biológicas associadas aos genes desta condição.

Synthesis of PIPs at the plasma membrane Synthesis of IP3 and IP4 in the cytosol Negative regulation of the PI3K/AKT network Downstream TCR signaling TP53 Regulates Metabolic Genes PTEN Loss of Function in Cancer Ub-specific processing proteases Ovarian tumor domain proteases Regulation of PTEN mRNA translation Regulation of PTEN localization Regulation of PTEN stability and activity Transcriptional Regulation by MECP2 Activation of BAD and translocation to mitochondria PIP3 activates AKT signaling Downregulation of ERBB2:ERBB3 signaling Translocation of SLC2A4 (GLUT4) to the plasma membrane Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation MTOR signalling AKT phosphorylates targets in the cytosol AKT phosphorylates targets in the nucleus eNOS activation AKT-mediated inactivation of FOXO1A Integrin signaling Deactivation of the beta-catenin transactivating complex CD28 dependent PI3K/Akt signaling Co-inhibition by CTLA4 G beta:gamma signalling through PI3Kgamma Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA KSRP (KHSRP) binds and destabilizes mRNA VEGFR2 mediated vascular permeability Constitutive Signaling by AKT1 E17K in Cancer Interleukin-4 and Interleukin-13 signaling Regulation of TP53 Degradation Regulation of TP53 Activity through Acetylation Regulation of TP53 Activity through Association with Co-factors PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Cyclin E associated events during G1/S transition Cyclin A:Cdk2-associated events at S phase entry PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 RAB GEFs exchange GTP for GDP on RABs Telomere Extension By Telomerase Formation of the beta-catenin:TCF transactivating complex Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence PI3K Cascade IRS-mediated signalling GPVI-mediated activation cascade Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants PI3K events in ERBB4 signaling Signaling by SCF-KIT GAB1 signalosome Signaling by cytosolic FGFR1 fusion mutants Downstream signal transduction PI3K events in ERBB2 signaling PI3K/AKT activation Signaling by ALK Role of phospholipids in phagocytosis Tie2 Signaling Constitutive Signaling by Aberrant PI3K in Cancer DAP12 signaling Role of LAT2/NTAL/LAB on calcium mobilization Nephrin family interactions G alpha (q) signalling events VEGFA-VEGFR2 Pathway Interleukin-3, Interleukin-5 and GM-CSF signaling Constitutive Signaling by EGFRvIII PI-3K cascade:FGFR1 PI-3K cascade:FGFR2 PI-3K cascade:FGFR3 PI-3K cascade:FGFR4 UCH proteinases Epigenetic regulation of gene expression by MLL3 and MLL4 complexes RMTs methylate histone arginines RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known Regulation of MITF-M-dependent genes involved in pigmentation Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) Formation of the canonical BAF (cBAF) complex Formation of the polybromo-BAF (pBAF) complex Formation of the embryonic stem cell BAF (esBAF) complex Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) PAOs oxidise polyamines to amines Interconversion of polyamines Antigen processing: Ubiquitination & Proteasome degradation Degradation of GLI1 by the proteasome Degradation of GLI2 by the proteasome GLI3 is processed to GLI3R by the proteasome Hedgehog 'off' state Hedgehog 'on' state Platelet degranulation Signaling by PDGF Non-integrin membrane-ECM interactions RAF/MAP kinase cascade Regulation of actin dynamics for phagocytic cup formation RHO GTPases activate PAKs

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado2
3Fase 31
2Fase 233
1Fase 17
·Pré-clínico57
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 100 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Tumor das meninges

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 19 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

60 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT06804655 · Pharmacoscopy for Patients With Refractory Primary Brain Tum…Recrutando
PHASE2🇨🇭 Suíça
NCT07652762 · IN10018 in Combination With Dalpiciclib for Progressive Meni…Recrutando
PHASE1🇨🇳 China
NCT07533942 · A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Mening…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT07398170 · Search for Circulating Tumour Cells in the Blood and/or Cere…Recrutando
NA🇫🇷 França
NCT07493447 · Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Im…Recrutando
EARLY_PHASE1🇺🇸 Estados Unidos
NCT07428616 · A Study of Zanzalintinib in Participants With Recurrent or P…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT07552233 · NK Cell Therapy for Malignant Solid Brain TumorsRecrutando
NA🇨🇳 China
NCT07411690 · Analysis of Cerebrospinal Fluid Leakage After Surgery for In…Recrutando
🇵🇱 Polônia
NCT07413796 · Comparison of Skin Closure Techniques in Oncological Neurosu…Recrutando
NA🇵🇱 Polônia
NCT07418775 · Tumor Genomics, Individual Risk Factors, and External Driver…Recrutando
🇺🇸 Estados Unidos
NCT07150806 · RYZ101 for the Treatment of Progressive or Recurrent Intracr…Recrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT06930846 · HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Train…Recrutando
NA🇺🇸 Estados Unidos
NCT06955169 · Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, …Recrutando
PHASE2🇺🇸 Estados Unidos
NCT06831461 · Proton Versus Photon Radiotherapy in Adults With Primary Bra…Recrutando
NA🇮🇳 Índia
NCT07044076 · Translation and Validation of the MQOL Self-questionnaire In…Recrutando
🇫🇷 França
NCT07056023 · Multicenter Trial on Surgical Outcome and Quality of Life in…Recrutando
🇩🇪 Alemanha
NCT05940493 · Abemaciclib in Newly Diagnosed Meningioma PatientsRecrutando
PHASE2🇺🇸 Estados Unidos
NCT06874426 · The Impact of Endoscopic Endonasal Skull Base Surgery on Olf…Recrutando
🇧🇪 Bélgica · 🇩🇪 Alemanha · 🇳🇱 Países Baixos
NCT06326190 · 177Lu-DOTATATE for Recurrent MeningiomaRecrutando
PHASE2🇦🇹 Áustria · 🇫🇷 França · 🇩🇪 Alemanha +3
NCT06878469 · SIMPLIFication of Care Pathways for Patients With Rare Brain…Recrutando
NA🇮🇹 Itália
NCT06132685 · Post-Operative Dosing of Dexamethasone in Patients With Brai…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT06752096 · Robot-Assisted Neurovascular InterventionRecrutando
NASouth Korea
NCT06830356 · Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose…Recrutando
NA🇮🇹 Itália
NCT06557512 · Adjuvant Hypofractionated Stereotactic Radiosurgery for Inte…Recrutando
NA🇺🇸 Estados Unidos
NCT06650163 · Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tom…Recrutando
PHASE1🇺🇸 Estados Unidos
NCT06126588 · Combination of Everolimus and 177Lu-DOTATATE in the Treatmen…Recrutando
PHASE2🇫🇷 França
NCT06640582 · TIL Therapy Combined With Pembrolizumab for Advanced Brain C…Recrutando
PHASE1, PHASE2🇨🇳 China
NCT06275919 · Regorafenib for Recurrent Meningioma (MIRAGE Trial)Recrutando
PHASE2🇮🇹 Itália
NCT06377371 · Feasibility of Intraoperative Tracing of Meningioma Using [C…Recrutando
PHASE4🇺🇸 Estados Unidos
NCT06632860 · A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- …Recrutando
EARLY_PHASE1🇨🇳 China
NCT06710249 · Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Ed…Recrutando
PHASE2🇸🇪 Suécia
NCT06104930 · Plasma Extracellular Vesicles in Meningioma PatientsRecrutando
NA🇩🇪 Alemanha
NCT05636618 · Targeted Alpha-Particle Therapy for Advanced Somatostatin Re…Recrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT06036706 · Neurocognitive Impact of Different Irradiation Modalities fo…Recrutando
NA🇫🇷 França
NCT06014905 · Feasibility of Acquiring Hyperpolarized Imaging in Patients …Recrutando
PHASE1🇺🇸 Estados Unidos
NCT05727605 · Neurocognition After Radiotherapy in CNS- and Skull-base Tum…Recrutando
NA🇧🇪 Bélgica
NCT05957679 · MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and …Recrutando
NA🇨🇳 China
NCT05278208 · Lutathera for Treatment of Recurrent or Progressive High-Gra…Recrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT06955208 · 3D MRE-Based Evaluation of Meningioma Mechanical Properties …Recrutando
NA🇨🇳 China
NCT05416567 · Embolization for MeningiomaRecrutando
NA🇳🇴 Noruega
NCT05139277 · Evaluation of the CONVIVO SystemRecrutando
NA🇺🇸 Estados Unidos
NCT05425004 · Cabozantinib for Patients With Recurrent or Progressive Meni…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT04997317 · Treatment of Recurrent or Progressive Meningiomas With the R…Recrutando
PHASE1, PHASE2🇨🇭 Suíça
NCT05793034 · Predictive Factors for Survival in Aggressive MeningiomasRecrutando
NA🇮🇹 Itália
NCT04427384 · Registry of Patients With Brain Tumors Treated With STaRT (G…Recrutando
🇺🇸 Estados Unidos
NCT04501705 · Apatinib in the Treatment of Recurrent Atypical/malignant Me…Recrutando
NA🇨🇳 China
NCT04374305 · Innovative Trial for Understanding the Impact of Targeted Th…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT04082520 · Lutathera for the Treatment of Inoperable, Progressive Menin…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT04278118 · Hypofractionated Proton Therapy for Benign Intracranial Brai…Recrutando
NA🇺🇸 Estados Unidos
NCT04635657 · Cognitive Status After Removal of Skull Base MeningiomaRecrutando
🇺🇸 Estados Unidos
NCT04104529 · Clinico-biological Database in Patients Treated With Metabol…Recrutando
NA🇫🇷 França
NCT04081701 · 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of So…Recrutando
PHASE4🇺🇸 Estados Unidos
NCT04343157 · UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracr…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT04648462 · Proton Therapy Research Infrastructure- ProTRAIT- Neuro-onco…Recrutando
🇳🇱 Países Baixos
NCT03702309 · Liquid Biopsy Evaluation and Repository Development at Princ…Recrutando
🇨🇦 Canadá
NCT02523014 · Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abem…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT05576103 · Longitudinal Prospective Study of Neurocognition & Neuroimag…Recrutando
🇺🇸 Estados Unidos
NCT00598351 · Natural History Study of Patients With Neurofibromatosis Typ…Recrutando
🇺🇸 Estados Unidos
NCT05254197 · SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)Recrutando
South Korea
NCT06753617 · Cryoablation of Brain NeoplasmPor convite
NA🇳🇱 Países Baixos

Outros ensaios clínicos

226 ensaios clínicos encontrados, 90 ativos.

Distribuição por fase
NCT06787807 · Proteomic Analysis of Patients Undergoing Bariatric SurgeryEm breve
NA🇧🇷 Brasil
NCT07823985 · Preoperative Embolization for Highly Vascular Brain TumorsEm breve
NA
NCT07809178 · China Treatment Trial for Tumor in Sellar Region With Unrupt…Em breve
🇨🇳 China
NCT07708285 · Luvometinib in Combination With Serplulimab for NF2-Related …Em breve
PHASE1, PHASE2🇨🇳 China
NCT07398066 · DEXmedetomidine for Postoperative Analgesia and Delirium Pre…Em breve
NA
NCT07713745 · Platform Research for Innovative Medicines in NF2-SWN (PRIME…Em breve
PHASE2🇨🇳 China
NCT07707947 · Selumetinib for NF2-Related SchwannomatosisEm breve
PHASE2🇨🇳 China
NCT07599917 · Diagnostic Performance and Quantitative Analysis of [18F]FET…Em breve
NCT07428213 · Measurement of PSMA Expression in Vivo in Recurrent Meningio…Em breve
NA🇫🇷 França
NCT07376473 · Psychometric Validation of the MQOL-FR and Descriptive Asses…Em breve
NCT07172178 · γδ T-PD-1 Ab Cells in the Treatment of Malignant MeningiomaEm breve
EARLY_PHASE1
NCT06937268 · DOTATATE PET for Meningioma Radiation PlanningEm breve
NA🇨🇦 Canadá
NCT02978677 · Proton Dose Escalation for Patients With Atypical or Anaplas…Em breve
NA
NCT07282470 · Epigenetic Profiling and Liquid Biopsy: Perspectives for Per…Ativo
🇮🇹 Itália
NCT06466720 · Measuring and Mapping Cognitive Decline After Brain Radiosur…Ativo
🇬🇧 Reino Unido
NCT04638478 · PREselection of Patients at Risk for COgnitive DEcline After…Ativo
🇳🇱 Países Baixos
NCT04659811 · Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) …Ativo
PHASE2🇺🇸 Estados Unidos
NCT04189172 · MiDura-Study (Neuro-Patch in Duraplasty)Ativo
🇫🇷 França · 🇩🇪 Alemanha
NCT04087902 · Long-Term Longitudinal QoL in Patients Undergoing EEAAtivo
🇺🇸 Estados Unidos
NCT03604978 · Nivolumab and Multi-fraction Stereotactic Radiosurgery With …Ativo
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT03971461 · Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With…Ativo
PHASE2🇺🇸 Estados Unidos
NCT03583528 · DOTATOC PET/CT for Imaging NET PatientsAtivo
🇨🇦 Canadá
NCT03279692 · Phase II Trial of Pembrolizumab in Recurrent or Residual Hig…Ativo
PHASE2🇺🇸 Estados Unidos
NCT03071874 · Vistusertib (AZD2014) For Recurrent Grade II-III MeningiomasAtivo
PHASE2🇺🇸 Estados Unidos
NCT03180268 · Observation or Radiation Therapy in Treating Patients With N…Ativo
PHASE3🇨🇦 Canadá · 🇮🇳 Índia · 🇯🇵 Japão +2
NCT03220646 · Abemaciclib (LY2835219) in Patients With Recurrent Primary B…Ativo
PHASE2🇺🇸 Estados Unidos
NCT02933736 · Ribociclib (LEE011) in Preoperative Glioma and Meningioma Pa…Ativo
EARLY_PHASE1🇺🇸 Estados Unidos
NCT02648997 · An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipili…Ativo
PHASE2🇺🇸 Estados Unidos
NCT02693990 · A Trial of Increased Dose Intensity Modulated Proton Therapy…Ativo
NA🇺🇸 Estados Unidos
NCT01892397 · Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical …Ativo
NA🇺🇸 Estados Unidos
NCT07476404 · Re-bleeding in Giant Meningioma and Intraoperative Hydroxyet…Concluído
Thailand
NCT06460467 · Semi-automatic Segmentation Method for Determining 177Lu-DOT…Concluído
🇫🇷 França
NCT06614205 · Tumor Absorbed Dose-Response Relationship in Patients Treate…Concluído
🇫🇷 França
NCT06255249 · Multicenter Evaluation in Patients With MEningiomas of the R…Concluído
🇫🇷 França
NCT06668987 · A Study of the Boron Neutron Capture Therapy (BNCT) Using B1…Concluído
PHASE1, PHASE2🇹🇼 Taiwan
NCT06439420 · CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized …Concluído
PHASE2🇺🇸 Estados Unidos
NCT05537675 · Semi-automated Segmentation Methods of SSTR PET for Dosimetr…Concluído
🇫🇷 França
NCT05305378 · Intraoperative Laser Speckle Contrast Imaging of Cerebral Bl…Concluído
🇺🇸 Estados Unidos
NCT05028400 · Intraoperative Laser Speckle Contrast Imaging to Assess Bloo…Concluído
NA🇨🇭 Suíça
NCT04743310 · Fluorescence Detection of Adult Primary Central Nervous Syst…Concluído
PHASE2🇺🇸 Estados Unidos
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Tumor das meninges.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Tumor das meninges e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É uma neoplasia benigna ou maligna que tem origem nas meninges, as membranas que envolvem o sistema nervoso central. A maior parte desses tumores surge a partir de células meningoteliais e recebe o nome de meningioma.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

4 publicações do grafo RarasNet (PubMed) · 7 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:252025
    Orphanet
  2. GARD:20737
    GARD (NIH)
  3. Q369157
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Tumor das meninges. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/tumor-das-meninges

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Tumor das meninges
Compêndio · Raras BR

Tumor das meninges

ORPHA:252025 · MONDO:0016743
Ensaios
90 ativos
MedGen
UMLS
C0025284
EuropePMC
Wikidata
Wikipedia
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Rara